Conceptually, the integration of rationally designed Piezo1 modulation with Chimeric Antigen Receptor Natural Killer Cell Therapy (CAR-NK) holds potential to mitigate on-target off-tumor toxicities such as neurotoxicity by precisely fine-tuning NK cell activation thresholds (18, 19). The gene discussed is PIEZO1; the disease is neoplasm.